Intangible Assets (Details) $ in Thousands, £ in Millions, $ in Millions	1 Months Ended		3 Months Ended
	Aug. 31, 2022 USD ($)	Jul. 31, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2023 USD ($)	May 31, 2022 USD ($)	May 31, 2022 GBP (£)	May 31, 2022 CAD ($)
Recognized Intangible Assets [Abstract]
Remaining weighted average estimated useful lives			15 years 3 months 18 days
Gross amount			$ 155,284
Less: accumulated amortization			(10,247)
Net book value			145,037		$ 144,881
Future amortization expense, remainder of 2024			7,100
Future amortization expense, 2025			9,500
Future amortization expense, 2026			9,500
Future amortization expense, 2027			9,500
Future amortization expense, 2028			9,500
Future amortization expense, thereafter			100,100
Cost of Revenues [Member]
Recognized Intangible Assets [Abstract]
Amortization of intangible assets			$ 2,400	$ 700
GSK [Member]
Intangible Assets [Abstract]
Milestone payable						$ 126,000	£ 100.0
Milestone amount paid		$ 126,000
Welichem Biotech Inc [Member]
Intangible Assets [Abstract]
Milestone payable						$ 20,000		$ 25.0
Milestone amount paid	$ 20,000